INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

GABELLI FUNDS LLC's Holding History (CIK: 0001081407)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 178,800 Value ($000) $3,315 Avg Close — Range —
Q3 2022
Shares 14,000 Value ($000) $195 Avg Close — Range —
Q2 2022
Shares 14,000 Value ($000) $193 Avg Close — Range —
Q1 2022
Shares 14,000 Value ($000) $228 Avg Close — Range —
Q4 2021
Shares 14,000 Value ($000) $228 Avg Close — Range —
Q3 2021
Shares 21,000 Value ($000) $312 Avg Close — Range —
Q2 2021
Shares 21,000 Value ($000) $419 Avg Close — Range —
Q1 2021
Shares 21,000 Value ($000) $485 Avg Close — Range —